The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
World Urbanization Prospects: The 1996 Revision
Brockerhoff, M., & Nations, U. (1998) · Population and Development Review · doi:10.2307/2808041 · Cited by 5,881
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642
Self-citationEconomic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600 · cited 2×
“[23], while programs in China showed a 42% reduction in the risk of developing type 2 diabetes during a 6-year follow-up, and in India a 28% risk reduction was observed over 3 years [24,25].”
BackgroundSelf-citationGlobal healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
Self-citationGlobal estimates of undiagnosed diabetes in adults
Beagley, J., Guariguata, L., Weil, C., & Motala, A. A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.001 · Cited by 586 · cited 3×
“[2] Beagley J, Guariguata L, Weil C, Motala AA.”
BackgroundInfluentialSelf-citationCost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M., & Zhang, X. (2010) · Diabetes Care · doi:10.2337/dc10-0843 · Cited by 491
Self-citationGuariguata, L., Whiting, D., Weil, C., & Unwin, N. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.040 · Cited by 441
Self-citationLifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications
Zhuo, X., Zhang, P., & Hoerger, T. J. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.04.017 · Cited by 272
Self-citationThe cost burden of diabetes mellitus: the evidence from Germany—the CoDiM Study
Köster, I., von Ferber, L., Ihle, P., Schubert, I., & Hauner, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0277-5 · Cited by 201
Economic burden of diabetes mellitus in the WHO African region
Kirigia, J. M., Sambo, H. B., Sambo, L. G., & Barry, S. P. (2009) · BMC International Health and Human Rights · doi:10.1186/1472-698x-9-6 · Cited by 159
Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran
Javanbakht, M., Baradaran, H. R., Mashayekhi, A., Haghdoost, A. A., Khamseh, M. E., Kharazmi, E., & Sadeghi, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026864 · Cited by 135
Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity
Yang, W., Zhao, W., Xiao, J., Li, R., Zhang, P., Kissimova‐Skarbek, K., Schneider, E., Jia, W., Ji, L., Guo, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039513 · Cited by 100
Self-citationCost of diabetes and its complications in Thailand: a complete picture of economic burden
Chatterjee, S., Riewpaiboon, A., Piyauthakit, P., Riewpaiboon, W., Boupaijit, K., Panpuwong, N., & Archavanuntagul, V. (2011) · Health & Social Care in the Community · doi:10.1111/j.1365-2524.2010.00981.x · Cited by 92
Huber, C. A., Schwenkglenks, M. M., Rapold, R., & Reich, O. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-44 · Cited by 68
Cited by
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Self-citationGenetics of diabetes mellitus and diabetes complications
Cole, J. B., & Florez, J. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0278-5 · Cited by 1,797
Type 2 diabetes and quality of life
Trikkalinou, A., Papazafiropoulou, A. K., & Melidonis, A. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i4.120 · Cited by 597
Microvascular Complications of Type 2 Diabetes Mellitus
Faselis, C., Katsimardou, A., Imprialos, K., Deligkaris, P., Kallistratos, M., & Dimitriadis, K. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161117666190502103733 · Cited by 549
Metadata
- Authors
- da Rocha Fernandes, J., Ogurtsova, K., Linnenkamp, U., Guariguata, L., Seuring, T., Zhang, P., Cavan, D., & Makaroff, L. E.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 117
- Pages
- 48-54
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2343344675
- Cited by
- 373
- References
- 18
- FWCI
- 98.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.